Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Ergonomics
|
July 7, 2024
Evaluation of self-contained breathing apparatus (SCBA) weight on firefighter stamina, comfort, and postural stability
Richard M Kesler, Jeffrey Powell, Dac Nguyen, et al.
Nature Communications
|
September 27, 2024
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial
Dalong Zhu, Weimin Wang, Guoyu Tong, et al.
Molecular Metabolism
|
June 26, 2023
Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
Wanjun Guo, Zheng Xu, Haixia Zou, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
February 13, 2026
Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study
Sudha Kodali, Ashton A Connor, David W Victor, et al.
Nature Communications
|
January 7, 2026
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial
Dalong Zhu, Weimin Wang, Guoyu Tong, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Ergonomics
|
July 7, 2024
Evaluation of self-contained breathing apparatus (SCBA) weight on firefighter stamina, comfort, and postural stability
Richard M Kesler, Jeffrey Powell, Dac Nguyen, et al.
Nature Communications
|
September 27, 2024
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial
Dalong Zhu, Weimin Wang, Guoyu Tong, et al.
Molecular Metabolism
|
June 26, 2023
Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
Wanjun Guo, Zheng Xu, Haixia Zou, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
February 13, 2026
Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study
Sudha Kodali, Ashton A Connor, David W Victor, et al.
Nature Communications
|
January 7, 2026
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial
Dalong Zhu, Weimin Wang, Guoyu Tong, et al.
Page
of 3